Pharmacological Modulation of Diacylglycerol-Sensitive TRPC3/6/7 Channels

  • Harteneck C
  • Gollasch M
91Citations
Citations of this article
62Readers
Mendeley users who have this article in their library.

Abstract

Members of the classic type of transient receptor potential channels (TRPC) represent important molecules in- volved in hormonal signal transduction. TRPC3/6/7 channels are of particular interest as they are components of phos- pholipase C driven signalling pathways. Upon receptor-activation, G-protein-mediated stimulation of phospholipase C re- sults in breakdown of phosphatidylinositides leading to increased intracellular diacylglycerol and inositol-trisphosphate levels. Diacylglycerol activates protein kinase C, but more interestingly diacylglycerol directly activates TRPC2/3/6/7 channels. Molecular cloning, expression and characterization of TRP channels enabled reassignment of traditional inhibi- tors of receptor-dependent calcium entry such as SKF-96365 and 2-APB as blockers of TRPC3/6/7 and several members of non-classic TRP channels. Furthermore, several enzyme inhibitors have also been identified as TRP channel blockers, such as ACA, a phospholipase A2 inhibitor, and W-7, a calmodulin antagonist. Finally, the naturally occurring secondary plant compound hyperforin has been identified as TRPC6-selective drug, providing an exciting proof of concept that it is possible to generate TRPC-selective channel modulators. The description of Pyr3 as the first TRPC3-selective inhibitor shows that not only nature but also man is able to generate TRP-selective modulators. The review sheds lights on the cur- rent knowledge and historical development of pharmacological modulators of TRPC3/6/7. Our analysis indicates that Pyr3 and hyperforin provide promising core structures for the development of new, selective and more potent modulators of TRPC3/6/7 activity.

Cite

CITATION STYLE

APA

Harteneck, C., & Gollasch, M. (2010). Pharmacological Modulation of Diacylglycerol-Sensitive TRPC3/6/7 Channels. Current Pharmaceutical Biotechnology, 12(1), 35–41. https://doi.org/10.2174/138920111793937943

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free